Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
American Journal of Nephrology
JournalCitation impact & published research
American Journal of Nephrology is a journal indexed in ScholarIQ from OpenAlex. ScholarIQ records 5,193 works, 176,123 citations and an h-index of 127.
5,193
Works
176,123
Citations
127
h-index
IDs:OpenAlex
What are the most-cited papers on American Journal of Nephrology?
ScholarIQmost cited works
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Rimda Wanchoo, Sabine Karam, Nupur N. Uppal, Valerie S. Barta, Gilbert Deray, Craig Devoe, Vincent Launay‐Vacher, Kenar D. Jhaveri, on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors
American Journal of Nephrology. 201715,290 CitationsOPEN ACCESS
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Francesco Locatelli, Steven Fishbane, Geoffrey A. Block, Iain C. Macdougall
American Journal of Nephrology. 20174,817 CitationsOPEN ACCESS
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Lee A. Hebert, Samir M. Parikh, Jason Prosek, Tibor Nádasdy, Brad H. Rovin
American Journal of Nephrology. 20134,380 CitationsOPEN ACCESS
Dialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
Finnian R. Mc Causland, Steven M. Brunelli, Sushrut S. Waikar
American Journal of Nephrology. 20132,699 CitationsOPEN ACCESS
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
Csaba P. Kövesdy, Susan L. Furth, Carmine Zoccali
American Journal of Nephrology. 20172,222 CitationsOPEN ACCESS
Related on ScholarIQ
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Paper
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Paper
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Paper
Dialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
Paper
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
Paper
History of Erythropoiesis-Stimulating Agents, the Development of Biosimilars, and the Future of Anemia Treatment in Nephrology
Paper